Document is current
Any future updates will be listed below
-
Authors
Clark, Virginia C.
Park, Suna
Krupnick, Robert
Sparling, Nicole
Ritchie, Jason
Karki, Chitra
Reynolds, Justin A.
-
Funding
Funding for this research was provided by:
Takeda Development Center Americas, Inc.
- License Information
-
More Information
Article History
Accepted: 12 February 2025
First Online: 13 March 2025
Declarations
:
: VCC has received research support from Novo Nordisk, Takeda, and Vertex, and consulting fees from Takeda and Vertex. SP and CK are employees and stockholders of Takeda Development Center Americas, Inc. RK, NS, and JR are employees of IQVIA, which received funding for this study from Takeda Development Center Americas, Inc. JAR has received consulting fees from Gilead and Takeda, and speaker’s bureau fees from AbbVie.
: All research was conducted in accordance with both the Declarations of Helsinki and Istanbul and approved by the Western Copernicus Group Institutional Review Board (formerly the Western Institutional Review Board). Consent was given in writing by all patients.
: Patients provided written consent for de-identified data to be published or presented.
